EUVIMEDEUVIMED entdecken
Crossref

Where does the development of new antituberculotics go? Part 2 - In vitro evaluation

Karel Waisser

Česká a slovenská farmacie · 2014

DOI: 10.36290/csf.2014.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Česká a slovenská farmacie, 2014. Verfasst von Karel Waisser. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Waisser, K. (2014). Where does the development of new antituberculotics go? Part 2 - In vitro evaluation. Česká a slovenská farmacie. https://doi.org/10.36290/csf.2014.003

Vancouver

Waisser K. Where does the development of new antituberculotics go? Part 2 - In vitro evaluation. Česká a slovenská farmacie. 2014. doi:10.36290/csf.2014.003

BibTeX
@article{Waisser2014,
  author = {Waisser, Karel},
  title = {Where does the development of new antituberculotics go? Part 2 - In vitro evaluation},
  journal = {Česká a slovenská farmacie},
  year = {2014},
  doi = {10.36290/csf.2014.003}
}
Kostenlos starten →